Parkinson's disease is the fastest-growing neurodegenerative disease, now affecting more than 10 million people worldwide, yet clinicians still face huge challenges in tracking its severity and progression.
Sep 21, 2022
0
80
If you've followed the news about Alzheimer's disease research in the past few months, you might find yourself wondering what else could go wrong.
Aug 1, 2022
1
469
An interactive web portal developed by scientists at KAUST offers a platform for cancer researchers to interrogate how RNA splicing in noncoding parts of genes fuels the growth of different types of tumors.
May 26, 2022
0
54
A new study by a University of Arkansas information systems researcher and his colleague at the University of Waikato in New Zealand shows that COVID vaccine trials conducted in geographic locations with low infection rates ...
May 24, 2022
0
105
The U.S. federal government spent an estimated $1.8 billion in Medicare funds in 2019 on drugs whose clinical benefits have yet to be confirmed by the Food and Drug Administration, a new study led by researchers from the ...
May 24, 2022
0
277
Less than half of Americans who received treatment for opioid use disorder over a five-year period were offered a potentially lifesaving medication, researchers at Washington University School of Medicine in St. Louis and ...
May 10, 2022
0
45
Most autoimmune diseases are easy to diagnose but hard to treat. A paper published today in Science proposes using your unique immune cell fingerprint to rapidly identify which treatments will work for your autoimmune disease.
Apr 7, 2022
0
507
The antiviral therapies remdesivir, molnupiravir, and the active ingredient in Pfizer's Paxlovid pill (nirmatrelvir), remain effective in laboratory tests against the BA.2 variant of SARS-CoV-2, the virus that causes COVID-19.
Mar 10, 2022
0
123
A pair of researchers, one with the University of Pennsylvania, the other Boston University, has published a Policy Forum piece in the journal Science outlining problems with fast-tracking drugs for use in the U.S. and suggest ...
A new University of Chicago study has found that the drug masitinib may be effective in treating COVID-19.
Jul 21, 2021
0
236
